202 related articles for article (PubMed ID: 19453546)
1. Parallel underexpression of kallikrein 5 and kallikrein 7 mRNA in breast malignancies.
Li X; Liu J; Wang Y; Zhang L; Ning L; Feng Y
Cancer Sci; 2009 Apr; 100(4):601-7. PubMed ID: 19453546
[TBL] [Abstract][Full Text] [Related]
2. KLK5 and KLK7, two members of the human tissue kallikrein family, are differentially expressed in lung cancer.
Planque C; de Monte M; Guyetant S; Rollin J; Desmazes C; Panel V; Lemarié E; Courty Y
Biochem Biophys Res Commun; 2005 Apr; 329(4):1260-6. PubMed ID: 15766562
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of kallikrein-related peptidase 5 expression and its significance for breast cancer patients: association with kallikrein-related peptidase 7 expression.
Talieri M; Devetzi M; Scorilas A; Prezas P; Ardavanis A; Apostolaki A; Karameris A
Anticancer Res; 2011 Sep; 31(9):3093-100. PubMed ID: 21868565
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein gene downregulation in breast cancer.
Yousef GM; Yacoub GM; Polymeris ME; Popalis C; Soosaipillai A; Diamandis EP
Br J Cancer; 2004 Jan; 90(1):167-72. PubMed ID: 14710225
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of kallikrein-related peptidase 7 (KLK7) in colorectal cancer.
Talieri M; Mathioudaki K; Prezas P; Alexopoulou DK; Diamandis EP; Xynopoulos D; Ardavanis A; Arnogiannaki N; Scorilas A
Thromb Haemost; 2009 Apr; 101(4):741-7. PubMed ID: 19350120
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the human kallikrein gene 5 (KLK5) in prostate cancer tissues.
Yousef GM; Scorilas A; Chang A; Rendl L; Diamandis M; Jung K; Diamandis EP
Prostate; 2002 May; 51(2):126-32. PubMed ID: 11948967
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.
Gong W; Liu Y; Diamandis EP; Kiechle M; Bronger H; Dorn J; Dreyer T; Magdolen V
J Ovarian Res; 2020 Oct; 13(1):125. PubMed ID: 33087135
[TBL] [Abstract][Full Text] [Related]
8. Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function.
Dong Y; Matigian N; Harvey TJ; Samaratunga H; Hooper JD; Clements JA
Biol Chem; 2008 Feb; 389(2):99-109. PubMed ID: 18163887
[TBL] [Abstract][Full Text] [Related]
9. Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.
Dong Y; Kaushal A; Brattsand M; Nicklin J; Clements JA
Clin Cancer Res; 2003 May; 9(5):1710-20. PubMed ID: 12738725
[TBL] [Abstract][Full Text] [Related]
10. Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer.
Kim H; Scorilas A; Katsaros D; Yousef GM; Massobrio M; Fracchioli S; Piccinno R; Gordini G; Diamandis EP
Br J Cancer; 2001 Mar; 84(5):643-50. PubMed ID: 11237385
[TBL] [Abstract][Full Text] [Related]
11. Specific increase of human kallikrein 4 mRNA and protein levels in breast cancer stromal cells.
Mangé A; Desmetz C; Berthes ML; Maudelonde T; Solassol J
Biochem Biophys Res Commun; 2008 Oct; 375(1):107-12. PubMed ID: 18687310
[TBL] [Abstract][Full Text] [Related]
12. Parallel overexpression of seven kallikrein genes in ovarian cancer.
Yousef GM; Polymeris ME; Yacoub GM; Scorilas A; Soosaipillai A; Popalis C; Fracchioli S; Katsaros D; Diamandis EP
Cancer Res; 2003 May; 63(9):2223-7. PubMed ID: 12727843
[TBL] [Abstract][Full Text] [Related]
13. The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
Yousef GM; White NM; Kurlender L; Michael I; Memari N; Robb JD; Katsaros D; Stephan C; Jung K; Diamandis EP
Tumour Biol; 2004; 25(5-6):221-7. PubMed ID: 15627884
[TBL] [Abstract][Full Text] [Related]
14. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
Park BW; Kim KS; Heo MK; Yang WI; Kim SI; Kim JH; Kim GE; Lee KS
J Surg Oncol; 2006 May; 93(6):504-10. PubMed ID: 16615154
[TBL] [Abstract][Full Text] [Related]
15. Expression analysis and study of KLK4 in benign and malignant breast tumours.
Papachristopoulou G; Avgeris M; Scorilas A
Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825
[TBL] [Abstract][Full Text] [Related]
16. Human kallikrein 10, a predictive marker for breast cancer.
Zhang Y; Bhat I; Zeng M; Jayal G; Wazer DE; Band H; Band V
Biol Chem; 2006 Jun; 387(6):715-21. PubMed ID: 16800732
[TBL] [Abstract][Full Text] [Related]
17. [mRNA expression of CK19 and CEA in peripheral blood of patients with breast cancer detected by real-time quantitative PCR].
Zheng HY; Chen Q; Ye YB; Huang WW
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(32):2267-70. PubMed ID: 19087676
[TBL] [Abstract][Full Text] [Related]
18. The GNA13-RhoA signaling axis suppresses expression of tumor protective Kallikreins.
Teo CR; Casey PJ; Rasheed SA
Cell Signal; 2016 Oct; 28(10):1479-88. PubMed ID: 27424208
[TBL] [Abstract][Full Text] [Related]
19. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP
Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991
[TBL] [Abstract][Full Text] [Related]
20. A multiparametric serum kallikrein panel for diagnosis of non-small cell lung carcinoma.
Planque C; Li L; Zheng Y; Soosaipillai A; Reckamp K; Chia D; Diamandis EP; Goodglick L
Clin Cancer Res; 2008 Mar; 14(5):1355-62. PubMed ID: 18316555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]